Technical analysis of Lixte Biotechnology Holdings, Inc. (LIXT): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Lixte Biotechnology Holdings, Inc. is a drug discovery company focused on developing new treatments. It employs biomarker technology to identify crucial enzyme targets associated with serious, widespread diseases, then designs innovative compounds to act upon these targets.
Price Performance
| 1 month | +0.00% |
| 3 months | -5.26% |
| Year-to-date | +83.46% |
| 1 year | +28.06% |
| 3 years | +285.56% |
| 5 years | -66.47% |
52-Week Range
| 52-week High | $8.38 |
| 52-week Low | $1.28 |
| Avg Volume (90d) | 175K |
Technical Indicators
| SMA 50 | $5.83 |
| SMA 200 | $4.31 |
| Beta | 0.95 |
| 30-day Volatility (annualised) | 106.6% |
| Price vs SMA 50 | +23.7% |
| Price vs SMA 200 | +67.2% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $4.29 | |
| 2025-11 | $4.27 | -0.5% |
| 2025-12 | $3.93 | -8.0% |
| 2026-01 | $3.72 | -5.3% |
| 2026-02 | $2.89 | -22.3% |
| 2026-03 | $3.07 | +6.2% |
| 2026-04 | $3.50 | +14.0% |
| 2026-05 | $6.25 | +78.6% |
| 2026-06 | $7.42 | +18.7% |
| 2026-07 | $7.21 | -2.8% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-14 | $-2.53 | |
| 2026-09-14 | | $159M |
| 2026-09-14 | $-0.26 | $14M |
| 2026-09-14 | | |
| 2026-09-14 | $0.84 | $26M |
| 2026-09-14 | | |
Price
| Price | $7.21 |
| Market Cap | $89M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 4.06 |
| EV / EBITDA | -30.96 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.05 |
| Current Ratio | 12.87 |